Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Perhexiline treatment increases the susceptibility of NB cells to antiblastic treatments
2016 Jun 5
with the exception of KLK3 at 1 nM in LNCaP cells
is a ACE inhibitor that protects the heart and helps reduce high blood pressure
3-dihydroxy-3-methylbutoxy]-7H-furo[3
CDK4/6-IN-2 indalone Perhexiline treatment increases the susceptibilityCDK4 6 IN 2 is a potent CDK4 and CDK6 inhibitor extracted from patent US20180000819A1, Compound 1, has IC50s of 2. 7 and 16 nM for CDK4 and CDK6, respectively. Product information CAS Number: 1800506 48 2 Molecular Weight: 506. 59 Formula: C27H32F2N8 Chemical Name: 5 [(4 ethylpiperazin 1 yl)methyl] N {5 fluoro 4 [4 fluoro 2 methyl 1 (propan 2 yl) 1H 1,3 benzodiazol 6 yl]pyridin 2 yl}pyrimidin 2 amine Smiles:
US$ 26.00
US$ 26.00
US$ 26.00
US$ 26.00
US$ 22.00